How do you account for treatment breaks longer than one week for patients with anal cancer receiving definitive chemoradiation?

I don’t think there is a “one size fits all” approach to this scenario and in general, practice is not supported by high level evidence. We do have a wealth of data to suggest that prolongation of the overall treatment time for squamous cell carcinoma (head/neck, uterine cervix, anal canal, etc) is ...